SEC FORM 4/A

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Mann Michael Scott

(Last)

(First)

(Middle)

6320 CANOGA AVENUE

(Street)

WOODLAND HILLS

91367

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
ENDONOVO THERAPEUTICS, INC. [ ENDV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	President

3. Date of Earliest Transaction (Month/Day/Year)
04/05/2017

4. If Amendment, Date of Original Filed (Month/Day/Year)
04/10/2017

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/05/2017	04/05/2017	P		1,000	A	$0.096	20,059,849	D
Common Stock	04/05/2017	04/05/2017	P		1,000	A	$0.0899	20,060,849	D
Common Stock	04/05/2017	04/05/2017	P		1,000	A	$0.0929	20,061,849	D
Common Stock	04/05/2017	04/05/2017	P		1,000	A	$0.0925	20,062,849	D
Common Stock	04/05/2017	04/05/2017	P		1,000	A	$0.089	20,063,849	D
Common Stock	04/05/2017	04/05/2017	P		1,000	A	$0.0924	20,064,849	D
Common Stock	04/05/2017	04/05/2017	P		1,000	A	$0.0923	20,065,849	D
Common Stock	04/05/2017	04/05/2017	P		1,000	A	$0.0912	20,066,849	D
Common Stock	04/06/2017	04/06/2017	P		1,000	A	$0.0737	20,067,849	D
Common Stock	04/06/2017	04/06/2017	P		1,000	A	$0.074	20,068,849	D
Common Stock	04/06/2017	04/06/2017	P		1,000	A	$0.077	20,069,849	D
Common Stock	04/06/2017	04/06/2017	P		1,000	A	$0.078	20,070,849	D
Common Stock	04/06/2017	04/06/2017	P		1,000	A	$0.079	20,071,849	D
Common Stock	04/06/2017	04/06/2017	P		1,000	A	$0.0808	20,072,849	D
Common Stock	04/06/2017	04/06/2017	P		1,000	A	$0.08	20,073,849	D
Common Stock	04/06/2017	04/06/2017	P		1,000	A	$0.077	20,074,849	D
Common Stock	04/06/2017	04/06/2017	P		1,000	A	$0.077	20,075,849	D
Common Stock	04/06/2017	04/06/2017	P		1,000	A	$0.0799	20,076,849	D
Common Stock	04/06/2017	04/06/2017	P		1,000	A	$0.081	20,077,849	D
Common Stock	04/06/2017	04/06/2017	P		1,000	A	$0.0849	20,078,849	D
Common Stock	04/06/2017	04/06/2017	P		1,000	A	$0.0848	20,079,849	D
Common Stock	04/07/2017	04/07/2017	P		1,000	A	$0.086	20,080,849	D
Common Stock	04/07/2017	04/07/2017	P		1,000	A	$0.087	20,081,849	D
Common Stock	04/07/2017	04/07/2017	P		1,000	A	$0.087	20,082,849	D
Common Stock	04/07/2017	04/07/2017	P		1,000	A	$0.087	20,083,849	D
Common Stock	04/07/2017	04/07/2017	P		1,000	A	$0.0881	20,084,849	D
Common Stock	04/07/2017	04/07/2017	P		1,000	A	$0.089	20,085,849	D
Common Stock	04/07/2017	04/07/2017	P		1,000	A	$0.089	20,086,849	D
Common Stock	04/07/2017	04/07/2017	P		1,000	A	$0.0881	20,087,849	D
Common Stock	04/07/2017	04/07/2017	P		1,000	A	$0.089	20,088,849	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

	Michael Mann	04/11/2017
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.